血清肿瘤标志物的应用与潜力，新的与旧的。 - Suppr

Suppr

超能文献

The use and potential of serum tumour markers, new and old.

作者信息

Bates S E

机构信息

Medicine Branch, National Cancer Institute, Bethesda, Maryland.

出版信息

Drugs. 1989 Jul;38(1):9-18. doi: 10.2165/00003495-198938010-00002.

DOI:10.2165/00003495-198938010-00002

PMID:2670513

Abstract

摘要

相似文献

The use and potential of serum tumour markers, new and old.

Drugs. 1989 Jul;38(1):9-18. doi: 10.2165/00003495-198938010-00002.

Correlation of tumour markers in ascitic fluid and serum: are measurements of ascitic tumour markers a futile attempt?

J Int Med Res. 2009 Jan-Feb;37(1):79-86. doi: 10.1177/147323000903700109.

[Serum tumour markers in asymptomatic patients].

Med Clin (Barc). 2015 Oct 5;145(7):319-20. doi: 10.1016/j.medcli.2015.03.008. Epub 2015 May 13.

The role of established tumour markers.

Ann Clin Biochem. 1991 Sep;28 ( Pt 5):527-8. doi: 10.1177/000456329102800522.

Serum tumor markers: past, state of the art, and future.

Int J Biol Markers. 2001 Apr-Jun;16(2):73-86.

When and how to use serum tumor markers in clinical practice.

Cleve Clin J Med. 1997 Jan;64(1):27-9. doi: 10.3949/ccjm.64.1.27.

Cancers Screening in an Asymptomatic Population by Using Multiple Tumour Markers.

PLoS One. 2016 Jun 29;11(6):e0158285. doi: 10.1371/journal.pone.0158285. eCollection 2016.

Search for serum tumor markers continues.

J Natl Cancer Inst. 1992 Mar 18;84(6):387-9. doi: 10.1093/jnci/84.6.387.

Tumour markers in the years to come; challenges, possibilities and goals.

Scand J Clin Lab Invest Suppl. 1991;206:102-5. doi: 10.3109/00365519109107731.

Autoantibody biomarkers in the detection of cancer.

Biochim Biophys Acta. 2006 Jun;1762(6):587-91. doi: 10.1016/j.bbadis.2006.04.001. Epub 2006 Apr 19.

本文引用的文献

AN " ACID " PHOSPHATASE OCCURRING IN THE SERUM OF PATIENTS WITH METASTASIZING CARCINOMA OF THE PROSTATE GLAND.

J Clin Invest. 1938 Jul;17(4):473-8. doi: 10.1172/JCI100974.

DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES.

J Exp Med. 1965 Mar 1;121(3):439-62. doi: 10.1084/jem.121.3.439.

Results of CEA-initiated second-look surgery for recurrent colorectal cancer.

Am J Surg. 1980 Apr;139(4):544-8. doi: 10.1016/0002-9610(80)90335-9.

Second-look laparotomy based on CEA elevations in colorectal cancer.

Cancer. 1981 May 1;47(9):2119-25. doi: 10.1002/1097-0142(19810501)47:9<2119::aid-cncr2820470903>3.0.co;2-7.

Evaluating the clinical efficacy of laboratory tests.

Am J Clin Pathol. 1983 Jan;79(1):78-86. doi: 10.1093/ajcp/79.1.78.

Clinical perspective of human colorectal cancer metastasis.

Cancer Metastasis Rev. 1984;3(4):303-24. doi: 10.1007/BF00051457.

A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.

N Engl J Med. 1983 Oct 13;309(15):883-7. doi: 10.1056/NEJM198310133091503.

Beta-subunit hCG and the control of trophoblastic disease.

Semin Oncol. 1982 Jun;9(2):187-90.

Carcinoembryonic antigen. A useful monitor of therapy of small cell lung cancer.

JAMA. 1981 Nov 13;246(19):2173-6. doi: 10.1001/jama.246.19.2173.

Serum alpha-fetoprotein in the early stage of human hepatocellular carcinoma.

Gastroenterology. 1984 Jun;86(6):1404-9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

The use and potential of serum tumour markers, new and old.

Drugs. 1989 Jul;38(1):9-18. doi: 10.2165/00003495-198938010-00002.

Correlation of tumour markers in ascitic fluid and serum: are measurements of ascitic tumour markers a futile attempt?

J Int Med Res. 2009 Jan-Feb;37(1):79-86. doi: 10.1177/147323000903700109.

[Serum tumour markers in asymptomatic patients].

Med Clin (Barc). 2015 Oct 5;145(7):319-20. doi: 10.1016/j.medcli.2015.03.008. Epub 2015 May 13.

The role of established tumour markers.

Ann Clin Biochem. 1991 Sep;28 ( Pt 5):527-8. doi: 10.1177/000456329102800522.

Serum tumor markers: past, state of the art, and future.

Int J Biol Markers. 2001 Apr-Jun;16(2):73-86.

When and how to use serum tumor markers in clinical practice.

Cleve Clin J Med. 1997 Jan;64(1):27-9. doi: 10.3949/ccjm.64.1.27.

Cancers Screening in an Asymptomatic Population by Using Multiple Tumour Markers.

PLoS One. 2016 Jun 29;11(6):e0158285. doi: 10.1371/journal.pone.0158285. eCollection 2016.

Search for serum tumor markers continues.

J Natl Cancer Inst. 1992 Mar 18;84(6):387-9. doi: 10.1093/jnci/84.6.387.

Tumour markers in the years to come; challenges, possibilities and goals.

Scand J Clin Lab Invest Suppl. 1991;206:102-5. doi: 10.3109/00365519109107731.

Autoantibody biomarkers in the detection of cancer.

Biochim Biophys Acta. 2006 Jun;1762(6):587-91. doi: 10.1016/j.bbadis.2006.04.001. Epub 2006 Apr 19.

本文引用的文献

AN " ACID " PHOSPHATASE OCCURRING IN THE SERUM OF PATIENTS WITH METASTASIZING CARCINOMA OF THE PROSTATE GLAND.

J Clin Invest. 1938 Jul;17(4):473-8. doi: 10.1172/JCI100974.

DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES.

J Exp Med. 1965 Mar 1;121(3):439-62. doi: 10.1084/jem.121.3.439.

Results of CEA-initiated second-look surgery for recurrent colorectal cancer.

Am J Surg. 1980 Apr;139(4):544-8. doi: 10.1016/0002-9610(80)90335-9.

Second-look laparotomy based on CEA elevations in colorectal cancer.

Cancer. 1981 May 1;47(9):2119-25. doi: 10.1002/1097-0142(19810501)47:9<2119::aid-cncr2820470903>3.0.co;2-7.

Evaluating the clinical efficacy of laboratory tests.

Am J Clin Pathol. 1983 Jan;79(1):78-86. doi: 10.1093/ajcp/79.1.78.

Clinical perspective of human colorectal cancer metastasis.

Cancer Metastasis Rev. 1984;3(4):303-24. doi: 10.1007/BF00051457.

A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.

N Engl J Med. 1983 Oct 13;309(15):883-7. doi: 10.1056/NEJM198310133091503.

Beta-subunit hCG and the control of trophoblastic disease.

Semin Oncol. 1982 Jun;9(2):187-90.

Carcinoembryonic antigen. A useful monitor of therapy of small cell lung cancer.

JAMA. 1981 Nov 13;246(19):2173-6. doi: 10.1001/jama.246.19.2173.

Serum alpha-fetoprotein in the early stage of human hepatocellular carcinoma.

Gastroenterology. 1984 Jun;86(6):1404-9.